Saint Helena vs Türkiye: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Saint Helena
2.0%
in 2024
Türkiye
0.0%
in 2024
Saint Helena rank
12th
Türkiye rank
13th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Saint Helena
- Türkiye
How they compare
Saint Helena currently reports 2.0% against 0.0% in Türkiye, a difference of 2.0%.
Across all 10 years both countries report, Saint Helena has been ahead every year.
Saint Helena ranks 12th and Türkiye ranks 13th of 215 countries.
Saint Helena has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Helena | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 0.1% | 2.6% | Saint Helena |
| 2020s | 2.3% | 0.1% | 2.3% | Saint Helena |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Saint Helena or Türkiye?
- Saint Helena, at 2.0% against 0.0% in Türkiye as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Saint Helena and Türkiye?
- 2.0%, with Saint Helena ahead.
- How many years of comparable data are there for Saint Helena and Türkiye?
- 10 years are reported by both, from 2015 to 2024.
- How do Saint Helena and Türkiye rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Saint Helena ranks 12th and Türkiye ranks 13th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.